Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-Triarylacrylamide Derivatives as Analogs of Combretastatin A-4

被引:0
作者
Jiang, Kun-Ming [1 ]
Dai, Xiao-Li [2 ]
Li, Ke [3 ]
Wu, Di [1 ]
Zhang, Ji-Hong [2 ]
Jin, Yi [1 ]
Lin, Jun [1 ]
机构
[1] Yunnan Univ, Sch Chem Sci & Technol, Lab Med Chem Nat Resource, Minist Educ, Kunming 650091, Peoples R China
[2] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650224, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Dept Med Oncol 1, Kunming 650031, Peoples R China
关键词
Cytotoxic activity; (E)-N,2,3-triarylacrylamide; SARs; synthesis; TUBULIN; AGENTS; GROWTH; CANCER; A4;
D O I
10.2174/1573406410666141226132926
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of (E)-N,2,3-triarylacrylamide derivatives were designed and synthesized as potent anticancer agents. Cytotoxicity of the 26 target compounds was evaluated in vitro against six cancer cell lines (HCT116, A549, MDA-MB-468, HepG2, SKNMC and SK-OV-3) by Sulforhodamine B colorimetric assay. The most promising compound, 4h, was as potent as the reference drug cisplatin (DDP). Preliminary structure-activity relationship (SAR) data provided guidance for further design and discovery of (E)-N, 2,3-triarylacrylamide scaffold anticancer agents.
引用
收藏
页码:453 / 461
页数:9
相关论文
共 17 条
[1]   In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes [J].
Aprile, Silvio ;
Del Grosso, Erika ;
Tron, Gian Cesare ;
Grosa, Giorgio .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) :2252-2261
[2]   Metabolism and roles of stilbenes in plants [J].
Chong, Julie ;
Poutaraud, Anne ;
Hugueney, Philippe .
PLANT SCIENCE, 2009, 177 (03) :143-155
[3]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[4]   Pharmaceutical design of antimitotic agents based on combretastatins [J].
Hsieh, HP ;
Liou, JP ;
Mahindroo, N .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (13) :1655-1677
[5]   Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors [J].
Jin, Y ;
Li, HY ;
Lin, LP ;
Tan, JZ ;
Ding, J ;
Luo, XM ;
Long, YQ .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (19) :5613-5622
[6]   4′-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3′,4′,5′-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents [J].
Jin, Yi ;
Zhou, Zu-Yu ;
Tian, Wei ;
Yu, Qiang ;
Long, Ya-Qiu .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (22) :5864-5869
[7]  
Kim R., 2005, CANCER, V103, P1880
[8]   An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site [J].
Lu, Yan ;
Chen, Jianjun ;
Xiao, Min ;
Li, Wei ;
Miller, Duane D. .
PHARMACEUTICAL RESEARCH, 2012, 29 (11) :2943-2971
[9]   The emergence of resistance to targeted cancer therapeutics [J].
Mellinghoff, IK ;
Sawyers, CL .
PHARMACOGENOMICS, 2002, 3 (05) :603-623